Wegovy
Your Trusted Source for Wegovy Treatments in Dubai

01
Wegovy 0.25 mg – Initial Starter Dose
Wegovy 0.25 mg is the starting point of the semaglutide treatment plan. This low-dose formulation is carefully designed to allow your body to adapt gradually to the medication while minimizing potential gastrointestinal side effects such as nausea or bloating. It is not intended for long-term use but rather as a preparatory dose before progressing to higher strengths. Used typically for the first 4 weeks, it helps introduce the hormone-based mechanism of semaglutide, which mimics GLP-1 (glucagon-like peptide-1), improving insulin release, reducing appetite, and delaying gastric emptying.
02
Wegovy 0.5 mg – Dose for Transition and Tolerance
After the body adjusts to the initial 0.25 mg dose, patients typically move up to Wegovy 0.5 mg. This dose supports the continued building of tolerance and further initiates appetite control and early-stage weight loss. It helps regulate blood sugar levels and provides additional metabolic benefits. This transitional dose is also short-term (around 4 weeks) and ensures your system is ready for stronger, more impactful dosages. This step-wise approach greatly reduces the risk of side effects while encouraging safe progression.


03
Wegovy 1 mg – Sustained Control and Progress
Wegovy 1 mg is often the first strength where patients start seeing noticeable improvements in both weight loss and glycemic control. By now, the body has adapted to semaglutide, and the appetite-reducing effects become more consistent. It provides continuous support for type 2 diabetes management and weight reduction goals, especially when combined with lifestyle changes such as a healthy diet and regular physical activity. This dose may be used for several weeks depending on the patient’s response and doctor’s guidance.
04
Wegovy 1.7 mg – Stronger Impact for Weight Loss
For patients who tolerate the lower doses well, Wegovy 1.7 mg introduces a stronger therapeutic effect. This dose delivers enhanced appetite suppression, increased metabolic support, and more significant weight loss potential. It also improves HbA1c levels for those managing type 2 diabetes. Typically used for a few weeks before transitioning to the final stage, this dose helps the body prepare for the full therapeutic benefits of Wegovy. It’s a crucial step for those aiming to reach substantial and sustained weight management results.


05
Wegovy 2.4 mg – Maximum Therapeutic Dose
Wegovy 2.4 mg is the highest and most effective dose of semaglutide approved for weight loss and chronic weight management. It is intended for long-term maintenance and is usually taken weekly after completing the dose escalation steps. This dose offers maximum appetite suppression, improved insulin sensitivity, better blood sugar regulation, and significant reductions in body weight. Clinical studies have shown impressive results with the 2.4 mg dose in obese or overweight individuals, especially when paired with a tailored health and nutrition plan. It’s the gold standard for patients seeking lasting transformation under medical supervision.